Ceritinib (Resistance)
Resistance
• Acquired Resistance: Over time, patients may develop resistance to ceritinib, often due to secondary mutations in the ALK gene or activation of alternative signaling pathways. Research is ongoing to develop new therapies to overcome this resistance